The principal forms of hydrocortisone include creams, injections, and tablets. Hydrocortisone cream is a topical medication applied directly to the skin to reduce inflammation, itching, and irritation caused by conditions such as eczema, dermatitis, and insect bites. These products are administered via different routes including parenteral, oral, and topical methods, addressing conditions such as adrenocortical dysfunction, adrenergic syndrome, hypercalcemia, thyroiditis, rheumatoid arthritis, dermatitis, asthma, chronic obstructive pulmonary disease (COPD), among others. Distribution channels for hydrocortisone products encompass hospital pharmacies, retail pharmacies, and online platforms.
The hydrocortisone market research report is one of a series of new reports that provides hydrocortisone market statistics, including hydrocortisone industry global market size, regional shares, competitors with an hydrocortisone market share, detailed hydrocortisone market segments, market trends and opportunities, and any further data you may need to thrive in the hydrocortisone industry. This hydrocortisone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hydrocortisone market size has grown strongly in recent years It will grow from $1.43 billion in 2023 to $1.52 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth observed in the historic period can be attributed to several factors, including the increasing prevalence of skin disorders, an aging population, heightened awareness and improved accessibility to treatments, growth within the pharmaceutical industry, and expansion into emerging markets.
The hydrocortisone market size is expected to see strong growth in the next few years It will grow to $1.96 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be attributed to advancements in technology, a surge in demand for over-the-counter (OTC) products, increased investments in research and development, rising disposable incomes, and expanded distribution channels. Key trends expected in the forecast period include a focus on natural ingredients, the development of combination therapies, personalized treatment options, the introduction of hydrocortisone-infused products, and a growing emphasis on sustainability.
The hydrocortisone market is expected to grow due to the increasing prevalence of inflammatory and autoimmune diseases. These conditions involve the immune system attacking the body's tissues, leading to chronic inflammation and tissue damage. The rising adoption of treatments for these diseases is driven by their growing prevalence and advancements in medical therapies. Hydrocortisone is utilized in severe asthma exacerbations and other inflammatory and autoimmune diseases to reduce inflammation and improve respiratory function quickly, often administered intravenously in emergency situations. For example, in May 2024, data from the National Center for Health Statistics indicated a rise in asthma prevalence among adults in the United States from 8.4% in 2021 to 8.7% in 2022, with an increase in asthma episodes from 3.3% to 3.7% over the same period.
Leading companies in the hydrocortisone market are focusing on developing combination therapies, such as lotions containing butyrate active ingredients, to enhance treatment effectiveness and expand their product offerings. Hydrocortisone combined with butyrate lotion aims to synergize anti-inflammatory properties with butyrate's immunomodulatory effects, potentially improving skin barrier function in managing skin conditions. For instance, in November 2023, J. Molner AS., an Estonian pharmaceutical firm, launched Hydrocortisone Butyrate Lotion, 0.1%, in the United States, marking a significant step in its strategy to expand globally. This product addresses inflammatory skin conditions, underscoring Molner's commitment to broadening its international market presence.
In March 2022, Advent International Corporation, a US-based private equity firm, acquired Perrigo Company plc's pharmaceutical businesses in Mexico and Brazil, aiming to bolster its regional investment strategy in the pharmaceutical sector. This acquisition strengthens Advent's position in the market, leveraging its extensive industry experience spanning more than two decades. Perrigo Company plc, based in Ireland, specializes in over-the-counter health and wellness solutions, including hydrocortisone creams.
Major companies operating in the hydrocortisone market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc, AbbVie Inc., Bayer AG, Novartis AG, The Dow Chemical Company, GlaxoSmithKline plc (GSK), Viatris Inc., Solvay SA, Teva Pharmaceutical Industries Ltd., Alcon Inc, Sandoz International GmbH, Valeant Pharmaceuticals International Inc, Fresenius Kabi AG, Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Ivax Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Limited, Impax Laboratories LLC, Akorn Incorporated, Taro Pharmaceutical Industries Ltd, Lannett Company Inc, Salix Pharmaceuticals Inc.
North America was the largest region in the hydrocortisone market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hydrocortisone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hydrocortisone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The hydrocortisone market consists of sales of hydrocortisone creams, ointments, lotions, and oral formulations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Hydrocortisone Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on hydrocortisone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hydrocortisone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hydrocortisone market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Cream; Injection; Tablet2) By Route Of Administration: Parenteral; Oral; Topical
3) By Application: Adrenocortical Dysfunction; Adrenergic Syndrome; High Blood Calcium; Thyroiditis; Rheumatoid Arthritis; Dermatitis; Asthma And Chronic Obstructive Pulmonary Disease; Other Application
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Key Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co Inc; AbbVie Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Pfizer Inc.
- Johnson & Johnson
- Merck & Co Inc
- AbbVie Inc.
- Bayer AG
- Novartis AG
- The Dow Chemical Company
- GlaxoSmithKline plc (GSK)
- Viatris Inc.
- Solvay SA
- Teva Pharmaceutical Industries Ltd.
- Alcon Inc
- Sandoz International GmbH
- Valeant Pharmaceuticals International Inc
- Fresenius Kabi AG
- Macleods Pharmaceuticals Limited
- Sun Pharmaceutical Industries Ltd.
- Bausch & Lomb Incorporated
- Hikma Pharmaceuticals PLC
- Aspen Pharmacare Holdings Limited
- Ivax Pharmaceuticals Inc
- Glenmark Pharmaceuticals Ltd.
- Torrent Pharmaceuticals Limited
- Impax Laboratories LLC
- Akorn Incorporated
- Taro Pharmaceutical Industries Ltd
- Lannett Company Inc
- Salix Pharmaceuticals Inc